Navigation Links
More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation
Date:9/21/2007

Cyclists from across the country will bike down the California coast to

raise funds and help those affected by arthritis

SAN FRANCISCO, Sept. 21 /PRNewswire-USNewswire/ -- More than 230 cyclists will kick off the seventh annual Amgen California Coast Classic Bike Tour on Saturday, September 29 in San Francisco. Participants, who will cycle down the California coastline over eight days, aim to raise more than $1.3 million this year for the Arthritis Foundation. The Amgen California Coast Classic will finish in Santa Monica at the Yahoo! Center on Saturday, October 6, after covering more than 520 miles.

"We are so proud that the Amgen California Coast Classic Bike Tour will be celebrating its seventh anniversary this year," said Dr. Robin Dore, chair of the Arthritis Foundation, Southern California Chapter, which organizes the Tour. "Since 2001, this event has raised more than $4 million, which continues to help the Arthritis Foundation support its research, education and advocacy for people living with arthritis. It has also been a great way for us to provide outreach to those suffering from arthritis, and their families."

The Amgen California Coast Classic Bike Tour is open to people of all ages and athletic ability. The goal of the event is to raise money to support arthritis research to find a cure, as well as to improve the quality of life for those who are affected by the more than 120 forms of arthritis. Arthritis is the country's leading cause of disability, afflicting nearly 46 million Americans, including more than 300,000 children. Arthritis-related diseases, such as lupus, fibromyalgia, rheumatoid arthritis, osteoporosis and scleroderma, can be seriously debilitating and sometimes life-threatening.

Deb Kennedy, a resident of San Ramon in Contra Costa County who will be riding in the Amgen California Coast Classic for the first time in 2007, said, "I'm pleased to be riding in 2007 as it marks my 10th year of living with rheumatoid arthritis. Biking has played a huge role in recovering and maintaining my health. I'm happy that I can ride in support of the Arthritis Foundation; I want others living with arthritis to feel as lucky as I do."

The 2007 Amgen California Coast Classic Bike Tour will pursue the following route:

-- Saturday, September 29 - San Francisco to Santa Cruz

-- Sunday, September 30- Santa Cruz to Monterey

-- Monday, October 1 - Monterey to Big Sur

-- Tuesday, October 2 - Big Sur to San Simeon

-- Wednesday, October 3 - San Simeon to Pismo Beach

-- Thursday, October 4 - Pismo Beach to Solvang

-- Friday, October 5 - Solvang to Ventura

-- Saturday, October 6 - Ventura to Los Angeles (Santa Monica)

To learn more, please call (800) 954-CURE (2873) or visit http://www.californiacoastclassic.org.

Amgen, the title sponsor of the California Coast Classic, is the world's leading biotechnology company, and a leader in inflammation research. Amgen has brought important therapies like Enbrel and Kineret to rheumatoid arthritis patients.

About the Arthritis Foundation

Established in 1948, the Arthritis Foundation is the only national voluntary organization that works on behalf of people with all forms of arthritis. The Arthritis Foundation funds research to find cures and improve care, issues up-to-date information about arthritis and its treatment, offers exercise and self-help classes and sponsors support and education groups. For more information, please call (800) 954-CURE (2873) or visit http://www.arthritis.org.


'/>"/>
SOURCE Arthritis Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Jamie Thomson to run California research lab
2. WiCell, California firm agree to distribute stem cell lines derived with new technique
3. Metavante to buy California software developer
4. California group says ruling weakens WARFs stem cell patent
5. Fiservs Banklink chosen by Union Bank of California
6. California investors acquire RedPrairie Corp.
7. Referendum may pull California to the forefront of stem cell research
8. Renaissance Learning will expand in Dallas and cut back California and Madison
9. Third Wave wins patent lawsuit against California firm
10. Tommy Thompsons ID chip, California firm to use WARFs patents and more ...
11. WARF signs stem cell agreement with California firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... York, NY (PRWEB) , ... April 28, 2016 ... ... QuickSTAT has made significant investments in recruiting top industry experts, and expanding its ... Platform, which provides industry-leading tools for clients to manage their clinical trial projects. ...
(Date:4/27/2016)... ... ... Cambridge Semantics, the leading provider of Smart Data analytic and ... named to The Silicon Review’s “20 Fastest Growing Big Data Companies of 2016.” ... needs of end users facing some of the most complex data challenges in the ...
(Date:4/27/2016)... ... , ... The Pittcon Organizing Committee is pleased to announce that Charles “Chuck” ... of Committee since 1987. Since then, he has served in a number of key ... for both the program and exposition committees. In his professional career, Dr. Gardner is ...
(Date:4/27/2016)... 2016 NanoStruck Technologies Inc. ... ( Frankfurt : 8NSK) gibt bekannt, ... 13. August 2015 die Genehmigung von der CNSX ... 200.000.000 Einheiten auf 400.000.000 Einheiten zu erhöhen, um ... wurden 157.900.000 Einheiten mit dem ersten Teil der ...
Breaking Biology Technology:
(Date:3/9/2016)... , March 9, 2016 This BCC ... future states of the RNA Sequencing (RNA Seq) market ... such as instruments, tools and reagents, data analysis, and ... various segments of the RNA-Sequencing market such as RNA-Sequencing ... Identify the main factors affecting each segment and forecast ...
(Date:3/8/2016)... 8, 2016   Valencell , the leading ... it has secured $11M in Series D financing. ... new venture fund being launched by UAE-based financial ... existing investors TDF Ventures and WSJ Joshua Fund. ... its triple-digit growth and accelerate its pioneering innovation ...
(Date:3/3/2016)... NOTTINGHAM, England and DE SOTO, ... , U.S.-based Stroke Detection Plus® to offer Oncimmune,s ... the risk assessment and early detection of lung cancer ... include large employers, unions and individuals. --> ... employers, unions and individuals. --> Oncimmune, a ...
Breaking Biology News(10 mins):